YEARBOOK & DIRECTORY
Fitzgibbon, David
Special Areas:David is a partner and Co-Head of the Firm's Corporate Department and Head of the Corporate M&A Group. He has extensive experience assisting clients across a range of industries on doing business in and from Ireland including advising on acquisitions/disposals, capital raisings, corporate migrations, cross-border mergers, joint ventures and reorganisations. He has worked extensively with a broad range of domestic and international corporations providing ongoing strategic advice to their boards.He has a broad-based practice reflecting his considerable experience across the agri-food, financial services, healthcare / life sciences and manufacturing sectors. David has significant experience advising on take-private transactions and has advised on many of Ireland’s most notable transactions. Career:Advising Smurfit Kappa Group plc on its pending $20 billion merger with WestRock Company to form Smurfit WestRock.Advising Horizon Therapeutics on all aspects of its acquisition by Amgen for aggregate consideration of $27 billion. Advising Zoom Video Communications, Inc on its acquisition of employee communication and engagement platform, Workvivo. Advising Novo Nordisk A/S on its acquisition of Neotope Neuroscience Limited for $100 million upfront and up to $1.2 billion in development and sales milestones payments. Advising Horizon Therapeutics on its $960 million underwritten public offering of ordinary shares. Advising Willis Towers Watson plc on its proposed $80 billion business combination with Aon plc. Advising Tirl?n Co-operative Society Limited on all aspects of its acquisition of Glanbia plc's interest in Glanbia Ireland, a dairy processing and consumer goods joint venture formed between Tirl?n Co-operative Society Limited and Glanbia plc. Advising Tirl?n Co-operative Society Limited on all aspects of the funding arrangements for its acquisition of Glanbia plc's 40% interest in Glanbia Ireland. (raising approximately €310m) comprised of a share placing by Tirl?n Co-op of approximately 2% of Glanbia plc's issued share capital together with the issue by Tirl?n Co-op of a €250m equity-linked exchangeable bond. Advising Horizon Therapeutics on its acquisition of EirGen Pharma's manufacturing facility in Waterford. Advising Smurfit Kappa Group on its November 2020 €660 million Share Placing. Qualifications:Trinity College Dublin (LLB with German)Law Society of Ireland, admitted as a solicitor
Fatal error: Uncaught Error: Call to undefined function print_main_area_end() in /var/www/financedublin.com/yearbook/advisers/person_details.php:198 Stack trace: #0 {main} thrown in /var/www/financedublin.com/yearbook/advisers/person_details.php on line 198 | ||||||||||||||||
